{"id":19658,"date":"2014-10-02T00:52:37","date_gmt":"2014-10-02T00:52:37","guid":{"rendered":"https:\/\/patientbloodmanagement.org\/resources\/un-testigo-de-jehova-con-leucemia-mieloide-aguda-tratado-con-exito-con-un-farmaco-epigenetico-la-azacitidina-una-pista-para-el-desarrollo-de-una-terapia-anti-lma-que-requiera-un-minimo-de-transfusio\/"},"modified":"2024-03-28T06:54:28","modified_gmt":"2024-03-28T06:54:28","slug":"un-testigo-de-jehova-con-leucemia-mieloide-aguda-tratado-con-exito-con-un-farmaco-epigenetico-la-azacitidina-una-pista-para-el-desarrollo-de-una-terapia-anti-lma-que-requiera-un-minimo-de-transfusio","status":"publish","type":"resources","link":"https:\/\/patientbloodmanagement.org\/es\/resources\/un-testigo-de-jehova-con-leucemia-mieloide-aguda-tratado-con-exito-con-un-farmaco-epigenetico-la-azacitidina-una-pista-para-el-desarrollo-de-una-terapia-anti-lma-que-requiera-un-minimo-de-transfusio\/","title":{"rendered":"Un testigo de Jehov\u00e1 con leucemia mieloide aguda tratado con \u00e9xito con un f\u00e1rmaco epigen\u00e9tico, la azacitidina: Una pista para el desarrollo de una terapia anti-LMA que requiera un m\u00ednimo de transfusiones sangu\u00edneas"},"content":{"rendered":"\n<p>Yamamoto Y, Kawashima A, Kashiwagi E, Ogata K.<\/p>\n\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25371835\" target=\"_blank\" rel=\"noopener\">Resumen<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Yamamoto Y, Kawashima A, Kashiwagi E, Ogata K. Resumen<\/p>\n","protected":false},"author":1,"featured_media":0,"template":"","categories":[252],"tags":[],"class_list":["post-19658","resources","type-resources","status-publish","hentry","category-drogas-es"],"acf":[],"_links":{"self":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources\/19658","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/users\/1"}],"wp:attachment":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/media?parent=19658"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/categories?post=19658"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/tags?post=19658"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}